Journal Information
Vol. 6. Issue 30.
Pages 128-142 (May - June 1992)
Vol. 6. Issue 30.
Pages 128-142 (May - June 1992)
Open Access
L'effectmtat del Cribatge del Cáncer de Mama en el Nostre Entorn
The Effectiveness of Breast Cancer Screening in Our Environs
La Efectividad del Cribaje del Cáncer de Mama en Nuestro Entorno
Visits
3837
X. Bonfill1,*, M.M. Marzo2, C. Medina1,3, P. Roura1, M. Rué1
1 Servei d'Epidemiologia i Informació Clíniques. Hospital de Sabadell. Consorci Hospitalari del Parc Taulí
2 Unitat de Salut Pública. Sector St. Feliu-Martorell. Regió Sanitària Costa de Ponent. Institut Català de la Salut
3 Sector de Sant Martí. Àrea de Gestió 8, Barcelona ciutat. Institut Català de la Salut
This item has received

Under a Creative Commons license
Article information
Resum

L'objectiu d'aquest article és revisar en quin estal es troba el cribatge del càncer de mama en el nostre país i quines podrien ser les directrius més aconsellables en intentar desenvolupar-lo. Es presenta primer I'impacte d'aquesta malaltia en el nostre país, per desprós incorporar I'evidència existent sobre I'eficàcia del cribatge A continuació es descriuen els principals programes i iniciatives que han intentat impulsar-lo. Finalment, es fan diverses recomanacions que semblen importants per tal d'aconseguir que el cribatge del càncer de mama no només sigui eficaç sinó també efectiu. Es conclou que és necessari que les autoritats sanitàries i professionals articulin i monitoritzin aquests programes.

Paraules clau:
Càncer
Mama
Cribalge
Summary

The aim of this paper is to review the current state of breast cancer screening in our country, as well as to discuss the most appropriate approaches for its development. Firstly, the impact of breast cancer in Spain is presented, as well as the current evidence about the efficacy of the screening. The major programs and initiatives addressed to promote screening are described. Finally, a few recommendations are given in order to achieve that breast cancer screening be, not only efficacious, but also effective. It is concluded that it is necessary that health and professional authorities coordinate and monitor breast cancer screening programs.

Key words:
Cancer
Breast
Screening
Resumen

El objetivo de este artículo es revisar en qué estado se encuentra el cribaje del cáncer de mama en nuestro país, y cuáles podrían ser las direclrices más aconsejables al intentar desarrollarlo. Se presenta el impacto de esta enfermedad en nuestro país, para despuée incorporar la evidencia existenle sobre la eficacia del cribaje. Se describen los principales programas e iniciativas que han intentado impulsarlo. Finalmente, se hacen una serie de recomendaciones que parecen importanles para conseguir que el cribaje del cáncer de mama no sólo sea eficaz, sino también efectivo. Se concluye que es necesario que las autoridades sanitarias y profesionales articulen y monitoricen estos programas.

Palabras clave:
Cáncer
Mama
Cribaje
Full text is only aviable in PDF
Bibliografía
[1.]
World Health Organization.
World Health Statistics Annual 1990.
World Health Organization, (1991),
[2.]
F. Bolumar, J. Vioque, A. Cayuela.
Changing mortality patterns lor major cancers in Spain, 1951–1985.
Int J Epidemiol, 20 (1991), pp. 20-25
[3.]
World Health Organization.
World Health Statistics Annual, 1980 a 1990.
World Health Organization, (1981 a 1991),
[4.]
M. Rué, J.M. Borràs, M. Mingot.
Mortalidad prematura por cáncer en España.
Jano (Monografías Médicas), 4 (1990), pp. 37-44
[5.]
Libro bianco de la Oncología en España..
Informe de la planificación global de la Oncología.
Jims S.A, (1988),
[6.]
Dades d'incidència del Regislre de Tumors de Tarragona 1987–1988. Resultats provisionals, 1990.
[7.]
D.M. Parkin, N.E. Day.
Evaluating and planning screening programmes.
The role of the registry in cancer control, pp. 45-63
[8.]
J. Kelsey, M.D. Gammon.
Epidemiology of breast cancer.
Epidemiologic Reviews, 12 (1990), pp. 228-240
[9.]
P. Strax.
Control of Breast Cancer Trough Mass Screening: From Research to Action.
Cancer, 63 (1989), pp. 1881-1887
[10.]
P. Viladiu, J. Borràs, J. Galceran, A. Izquierdo, M. Vallmajor.
Registres de càncer: unaeina per I'assistència, la docencia i la recerca en oncologia.
Salut Catalunya, 3 (1989), pp. 152-157
[11.]
X. Bonfill, C. Brotons, R. Hernández, P. Roura, R. Vergés, M.D. Conesa, E. Capdevila, M. Rué.
Estudi sobre la incidència i I'alenciõ sanitària dels pacients amb càncer de la població de Rubí Resultats preliminars.
Ajuntament de Rubí, (1990),
[12.]
R.N. Battista.
Early detection of cancer: an overview.
Ann Rev Public Health, 9 (1988), pp. 21-45
[13.]
S. Shapiro, W. Venet, P. Starx, L. Venet.
Current results of the breast cancer screening randomized trial: The Health Insurance Plan (HIP) ol Greater New York.
Inf J Cancer, (1990), pp. 76-84
[14.]
A.S. Morrison.
Review of evidence on the early defection and treatment of breast cancer.
Cancer, 64 (1989), pp. 2651-2656
[15.]
L. Tabár, C.J.G. Fagerberg, A. Gad, et al.
Reduction in mortality from breast cancer after mass screening with mamography. Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.
Lancet, 2 (1985), pp. 829-832
[16.]
I. Andersson, K. Aspegren, L. Janzon, et al.
Effect of mamographic screening on breast cancer mortality in a urban population in Sweden. Results from the randomized Malmö Mamographic Screening Trial (MMST).
Br Med J, 297 (1988), pp. 943-948
[17.]
UK Trial ol Early Detection of Breast Cancer Group.
First results on mortality reduction in the UK trial of early detection ot breast cancer.
Lancet, 2i (1988), pp. 411-416
[18.]
J. Frisell, G. Eklund, U. Hellstrom, E. Lidbrink, L.E. Rutqvist, A. Somell.
Randomized study ol mamography screening-preliminary report on mortality in the Stockholm trial.
Breast Cancer Res Treat, 18 (1991), pp. 49-56
[19.]
A.L.M. Verbeek, J.H.C.L. Hendriks, R. Holland, M. Mravunac, F. Sturmans, N.E. Day.
Reduction in breast cancer mortality through mass screening with modern mammography. (First results of the Nijmegen Project 1975–81).
Lancet, 1 (1984), pp. 1222-1224
[20.]
P.H.L. Peeters, A.L.M. Verbeek, J.H.C.L. Hendriks, M.J.H. Van Bon.
Screening for breast cancer in Nijmegen. Report of 6 screening rounds. 1975–1986.
Int J Cancer, 43 (1989), pp. 226-230
[21.]
H.J. Collette, N.E. Day, J.J. Rombach, F. deWaard.
Evaluation of screening for breast cancer in a non-randomised study (The DOM protect) by means of a cas-control study..
Lancet, 1 (1984), pp. 1224-1226
[22.]
D. Palli, M.R. Del Turco, E. Buiatti, et al.
A case-conlrol study of the efficacy of a nonrandomised breast cancer screening program in Florence (Italy).
Int J Cancer, 38 (1986), pp. 501-504
[23.]
A.P.M. Forrest.
Breast cancer: the decision to screen.
J Public Health Med, 13 (1991), pp. 2-12
[24.]
P. Skrabanek.
Mass Mammography Reappraisal.
Int J Technology Assessment in Health Care, 5 (1989), pp. 423-430
[25.]
N.E. Day, J. Baines, J. Chamberlain, M. Hakama, A.B. Miller, P. Prorok.
UICC Project on screening for Cancer: Report of the Workshop on Screening for Breast Cancer.
Int J Cancer, 83 (1986), pp. 303-308
[26.]
A.B. Miller.
The Canadian Breast Screening Study.
University of Toronto (Canada), (1989),
[27.]
Moss S, Chamberlain J. Trial to study the effects of screening starting at age 40 on breast cancer mortality. Progress report, 1990.
[28.]
N.E. Day, J. Chamberlain.
Screening for breast cancer.
Eur J Cancer Clin Oncol, 24 (1988), pp. 55-59
[29.]
S. Shapiro.
The Status of Breast Cancer Screening: A Quarter of a Century of Research.
World J Surgery, 13 (1989), pp. 9-18
[30.]
R.S.A. Hayward, E.P. Steinberg, D.E. Ford, M.F. Roizen, K.W. Roach.
Preventive care guidelines: 1991.
Ann Int Med, 114 (1991), pp. 758-783
[31.]
Comisión de las Comunidades Europeas.
Europa contra el Cáncer. Objetivo: Un 15% menos de víctimas en el año. 2000.
Programa Europa contra el Cáncer, (1989),
[32.]
A.P.M. Forrest.
Screening for Breast Cancer: the UK scene.
Br J Radiol, 62 (1989), pp. 695-704
[33.]
Generality de Catalunya, Departament tie Samtat i Seguretat Social.
Document marc per a l'elaboració del Pla de Salut de Catalunya.
Generalitat de Catalunya, Departament de Sanitat i Seguretat Social, (1991),
[34.]
Información oral facilitada por el Dr. González. Dirección General de Salud Pública, Ministerio de Sanidad y Consumo, 1992.
[35.]
C. Rodríguez, A. Plasencia, F. Ferrer, A. Gómez.
Programa PAM de detección temprana de cáncer de mama: primeros resultados (1987–1990).
Med Clin (Barc), 96 (1991), pp. 206-210
[36.]
J. Estapé.
Europa contra el cáncer. Monografías médicas.
JANO, 4 (1990), pp. 9-11
[37.]
Programa de detección Precoz del Cáncer de mama en Navarra, Servicio Regional de Salud. Gobiemo de Navarra, 1990.
[38.]
Programa de Prevención de Cáncer de mama en Navarra. Boletín Informativo «Europa Contra el Cáncer». Comisión de la Comunidad Europea Nº 5; julio-agosto 1991.
[39.]
Programa de detección precoz de cáncer de mama en Navarra. Servicio Regional de Salud. Prevención cáncer de mama. Dades facilitadades pel programa, 1991.
[40.]
Programa d'Activitats Preventives i de Promoció de la Salut en Atenció Primória. Red de Centros Investigadores de la SEMFYC (Sociedad Españoia de Medicira Familiar y Comunitaria). Desembre 1990.
[41.]
Equipo de Atención Primaria del CAP de la Mina (Barcelona). Resultados preliminares del programa de cribaje del cáncer de mama. Dalos facilitados por los propios autores, 1992.
[42.]
I.T. Gram, P.G. Lund-Larsen, A.F. Rosenlund, J. Strmer.
Mammography screening in Tromso Realization and results of the first mammography screening in Norway.
Tidsskr Nor Laegeloren, 109 (1989), pp. 1040-1042
[43.]
M. Pamilo, I. Anttinen, M. Roiha, et al.
Mammography screening for breast cancer: first year results from Helsinki and surroundings.
Ann Intern Med, 2 (1989), pp. 277-279
[44.]
L. Cirelli, F. Donato, M. Carafa, R. Spiazzi.
Results ol the first round of mammographic screening at local health unit No.43, Leno, Lombardy (Brescia).
Radiol Med (Torino), 77 (1989), pp. 382-385
[45.]
Coup de louet au dépistage. Impact Medecine, 6 Avril 1990.
[46.]
J. Brisson, A.S. Morrison, N. Khalid.
Mammographic Parenchymal Features and Breast Cancer in the Breast Cancer Detection Demonstration Project.
J Natl Cancer Inst, 80 (1988), pp. 1534-1540
[47.]
A.S. Morrison, J. Brison, N. Khalid.
Breast Cancer Incidence and Mortality in he Breast Cancer Detection Project.
J Natl Cancer Inst, 80 (1988), pp. 1540-1557
[48.]
R.P. Harris.
Mammography and age are we targeting the wrong? A community survey ol women and physicians.
Cancer, 67 (1991), pp. 2010-2014
[49.]
V. Koroltchouk, S. Kenneth, J. Stjernswärd.
The Control ol Breast Cancer.
Cancer, 65 (1990), pp. 2803-2810
[50.]
R.J. Brenner.
Screening Mammography.
Cancer Supplement, 66 (1990), pp. 1348-1350
[51.]
J.B. Witcombe.
A licence for Breast Cancer Screening?.
Br Med J, 296 (1988), pp. 909-911
[52.]
D. Mant, G. Fowler.
Mass Screening Theory and Ethics.
Br Med J, 300 (1990), pp. 916-918
[53.]
P. Norman, M. Fitler.
The potential and limitations of opportunist screening: data Irom a computer simulation of a general practice screening programme.
Br J Gen Prac, 41 (1991), pp. 188-191
[54.]
S.A. Flig.
Decreased Breast Cancer Mortality through Mammographic Screening: Results of Clinical Trials.
Radiology, 167 (1988), pp. 659-664
[55.]
Encuesta «Los Europeos y la prevención del cáncer». (CE, Bruselas, 1987).
[56.]
T.M. Marteau.
Reducing the psychological costs.
Br Med J, 301 (1990), pp. 26-28
[57.]
J.S. Spratt, S.W. Spratt.
Medial and Legal Implications of Screening and Follow-Up Procedures for Breast Cancer.
Cancer Supplement, 66 (1990), pp. 1351-1362
[58.]
R. Ciurana, E. Avellana, J. Martí.
Prevención del cáncer de mama: situación actual del cribaje.
Atenc Prim, 8 (1991), pp. 966-975
[59.]
J. Austoker.
Breast cancer screening and the primary care team.
Br J Med, 1 (1990), pp. 631-634
[60.]
L.E. Rutquist, A.B. Miller, I. Anderson, et al.
Reduced breast-cancer mortality with mammography screening. An assessment of current available data.
Int J Cancer, (1990), pp. 76-84
[61.]
K. Chu, C.R. Smart, R.E. Tarone.
Analysis of Breast Cancer Mortal ity and Stage Distribution by Age for the Health Insurance Plan Clinical Trial.
J Nat Cancer Inst, 80 (1988), pp. 1125-1132
[62.]
D. Eddy.
Screening for breast cancer.
Ann Int Med, 111 (1989), pp. 389-399
[63.]
M.T. Schechter, A.B. Miller, C.J. Baines, G.R. Howe.
Selection of women at high risk of breast cancer for initial screening.
J Chron Dis, 39 (1986), pp. 253-260
[64.]
C.J. Baines, D.V. McFarlane, A.B. Miller.
The role of the reference radiologist. Estimates of inter-observer agreement and potential delay in cancer detection in the national breast screening study.
Invest Radiol, 25 (1990), pp. 971-976
[65.]
Marzo MM, Serrasolsas RM, Mota C. Programa de detecció precoç de càncer de mama (Pòster). Congreso SESPAS; Oct 1991: València.
[66.]
A. Donabedian.
The definition ol quality and approaches to its assessment.
Health Administration Press, (1980),
[67.]
R. Mc Lelland, E.D. Pissano.
Issues in Mammography.
Cancer, 66 (1990), pp. 1341-1344
[68.]
A. Bull, L. Mountney, H. Sanderson.
Stage distribution of breast cancer: a basis for the evaluation of breast screening programmes.
Br J Radiol, 762 (1991), pp. 516-519
[69.]
R. Schweitzer, R. Murphy.
Panel V: Requirements for quality breast cancer detection.
Cancer, 64 (1989), pp. 2706
[70.]
G.R. Dodd.
Quality assurance in mammography.
Cancer, 64 (1989), pp. 2707-2709
[71.]
R.E. Hendrick.
Requirements for quality breast cancer detection: technical quality control.
Cancer, 64 (1989), pp. 2710-2717
[72.]
Council on Scientific Affairs.
Mammographic Screening in Asymptomatic Women Aged 40 Years and Older.
JAMA, 261 (1989), pp. 2535-2542
Copyright © 1992. Sociedad Española de Salud Pública y Administración Sanitaria
Idiomas
Gaceta Sanitaria
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?